I am a healthcare technology entrepreneur with more than three decades of experience building and scaling companies across healthcare, technology, and regulated markets.
Today, I serve as Co-Founder, Chairman, and CEO of iRemedy Healthcare, an AI-enabled procurement and supply chain platform supporting manufacturers, healthcare providers, and government agencies nationwide. Our work centers on advancing transparency, resilience, and efficiency across the medical supply chain through intelligent technology, logistics infrastructure, and direct partnerships with global manufacturers and distributors.
Throughout my career, I have founded and led multiple public and private companies, including Agency One (which evolved into Vertafore) and Medinex, an EMR software company that went public on NASDAQ. I am a co-inventor of twelve issued U.S. patents relating to AI-driven automation, data normalization, and machine learning systems designed to structure unstructured data and automate complex multi-step workflows at scale. Additional patents are pending.
In 2020, I led a federal program to procure and distribute more than one billion medical devices for the U.S. vaccination effort. That experience exposed profound vulnerabilities in global medical manufacturing and ultimately defined much of my work today.
On October 8, 2025, I testified before the U.S. Senate Special Committee on Aging at the hearing “Bad Medicine: Closing Loopholes that Kill American Patients,” providing firsthand insight into drug shortages, foreign manufacturing dependencies, and systemic supply-chain risks.
I am also the author of The End of Us: A Story of Death, Deception, and China’s Deadly Grip on U.S. Healthcare and The Retail Healthcare Revolution, which are both available on Amazon. I am also the host of The Supply Side Podcast, where I engage leaders across healthcare, logistics, technology, and manufacturing about the future of their industries.
My focus is on strengthening the U.S. medical supply chain through two parallel efforts: (1) enabling direct relationships between healthcare providers and global medical manufacturers; and (2) rebuilding domestic manufacturing capacity for critical drugs and supplies. I believe these reforms are essential for ensuring national health security and restoring resilience to the healthcare system.
Read more about me on https://grokipedia.com/page/tony-paquin
